A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance

d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain

(2014) Darrick T. Balu et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Clinical development success rates for investigational drugs

(2014) Michael Hay et al.   NATURE BIOTECHNOLOGY

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

(2014) Yoshiyuki Tsuda et al.   BMJ Open

Dual patch voltage clamp study of low membrane resistance astrocytes in situ

(2014) Baofeng Ma et al.   Molecular Brain

In Vivo d-Serine Hetero-Exchange through Alanine-Serine-Cysteine (ASC) Transporters Detected by Microelectrode Biosensors

(2013) Caroline Maucler et al.   ACS Chemical Neuroscience

Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development

(2013) Hugo Geerts et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Revitalizing Psychiatric Therapeutics

(2013) Steven E Hyman   NEUROPSYCHOPHARMACOLOGY

The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey

(2013) Donnie Eddins et al.   PSYCHOPHARMACOLOGY

A Quantitative Systems Pharmacology Computer Model for Schizophrenia Efficacy and Extrapyramidal Side Effects

(2012) Athan Spiros et al.   DRUG DEVELOPMENT RESEARCH

Dynamic models of BOLD contrast

(2012) Richard B. Buxton   NEUROIMAGE

NR2C in the Thalamic Reticular Nucleus; Effects of the NR2C Knockout

(2012) Yuchun Zhang et al.   PLoS One

Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response

(2012) Hugo Geerts et al.   PLoS One

Altered N-methyl-d-aspartate receptor function in reelin heterozygous mice: Male–female differences and comparison with dopaminergic activity

(2012) Maarten van den Buuse et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Supportive Psychodynamic Psychotherapy versus Treatment as Usual for First-Episode Psychosis: Two-Year Outcome

(2012) Bent Rosenbaum et al.   PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES

Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia

(2012) Christian Sorg et al.   SCHIZOPHRENIA BULLETIN

Default mode network activity in schizophrenia studied at resting state using probabilistic ICA

(2012) Gianluca Mingoia et al.   SCHIZOPHRENIA RESEARCH

Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action

(2012) Patrick D Roberts et al.   Alzheimers Research & Therapy

Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex

(2011) Pascal Fossat et al.   CEREBRAL CORTEX

First-Time-in-Human Study With GSK1018921, a Selective GlyT1 Inhibitor: Relationship Between Exposure and Dizziness

(2011) D Ouellet et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

(2011) Surendra P. Singh et al.   CNS DRUGS

NR2B phosphorylation at tyrosine 1472 in spinal dorsal horn contributed to N-methyl-D-aspartate-induced pain hypersensitivity in mice

(2011) Shuai Li et al.   JOURNAL OF NEUROSCIENCE RESEARCH

The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex

(2011) Darrick T. Balu et al.   NEUROBIOLOGY OF DISEASE

Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia

(2011) Daniela Alberati et al.   NEUROPHARMACOLOGY

Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence

(2011) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia

(2011) Adam J Funk et al.   NEUROPSYCHOPHARMACOLOGY

Developmental localization of NMDA receptors, Src and MAP kinases in mouse brain

(2011) Xiangning Jiang et al.   NEUROSCIENCE LETTERS

Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI

(2011) Amy Pinkham et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)

(2011) William P. Horan et al.   SCHIZOPHRENIA RESEARCH

Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors

(2010) Scott Wolkenberg et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia

(2010) Philippe-Olivier Harvey et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects

(2010) M Liem-Moolenaar et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B)

(2010) Akira Hokyo et al.   PSYCHIATRIC GENETICS

Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia

(2010) L.V. Kristiansen et al.   SCHIZOPHRENIA RESEARCH

Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia

(2010) Lars V. Kristiansen et al.   SYNAPSE

Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia

(2010) Guillermo Gonzalez-Burgos et al.   Current Psychiatry Reports

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse

(2010) Hugo Geerts   Neuropsychiatric Disease and Treatment

Transient Currents in the Glycine Cotransporter GlyT1 Reveal Different Steps in Transport Mechanism

(2009) Francesca Cherubino et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Impact of Serotonin 2C Receptor Null Mutation on Physiology and Behavior Associated with Nigrostriatal Dopamine Pathway Function

(2009) L. Abdallah et al.   JOURNAL OF NEUROSCIENCE

Characteristics of glycine transport across the inner blood–retinal barrier

(2009) Masashi Okamoto et al.   NEUROCHEMISTRY INTERNATIONAL

The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question

(2009) Vina M. Goghari et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Anhedonia and Ambivalence in Schizophrenic Patients with Fronto-Cerebellar Metabolic Abnormalities: A Fluoro-D-Glucose Positron Emission Tomography Study

(2009) Kyung-Min Park et al.   Psychiatry Investigation

COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET

(2008) M Slifstein et al.   MOLECULAR PSYCHIATRY

Over-expression of the potassium channel Kir2.3 using the dopamine-1 receptor promoter selectively inhibits striatal neurons

(2008) T. Falk et al.   NEUROSCIENCE

Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytes

(2007) Philip E. Chen et al.   JOURNAL OF PHYSIOLOGY-LONDON

Biophysical model for integrating neuronal activity, EEG, fMRI and metabolism

(2007) Roberto C. Sotero et al.   NEUROIMAGE